We speculate that up-regulation of METTL3 may promote the advancement of ESCC through m6A modification of CASP9 or BIRC3 mRNA, but the modulation of their expression depends on downstream “m6A reader” proteins. This evidence concerns the gene METTL3 and esophageal squamous cell carcinoma.